A detailed history of Us Bancorp \De\ transactions in Merck & Co., Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,965,777 shares of MRK stock, worth $198 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,965,777
Previous 2,011,783 2.29%
Holding current value
$198 Million
Previous $249 Million 10.37%
% of portfolio
0.29%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$111.15 - $128.97 $5.11 Million - $5.93 Million
-46,006 Reduced 2.29%
1,965,777 $223 Million
Q2 2024

Aug 06, 2024

SELL
$123.8 - $132.96 $1.67 Million - $1.8 Million
-13,519 Reduced 0.67%
2,011,783 $249 Million
Q1 2024

May 07, 2024

SELL
$113.24 - $131.95 $157,403 - $183,410
-1,390 Reduced 0.07%
2,025,302 $267 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $5.44 Million - $5.92 Million
-54,259 Reduced 2.61%
2,026,692 $221 Million
Q3 2023

Nov 03, 2023

BUY
$102.95 - $114.33 $41.4 Million - $46 Million
402,136 Added 23.95%
2,080,951 $214 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $58 Million - $63.2 Million
-534,162 Reduced 24.14%
1,678,815 $194 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $1.44 Million - $1.6 Million
-13,966 Reduced 0.63%
2,212,977 $235 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $38.3 Million - $49.1 Million
438,307 Added 24.51%
2,226,943 $247 Million
Q3 2022

Oct 27, 2022

SELL
$84.53 - $94.96 $8.43 Million - $9.47 Million
-99,719 Reduced 5.28%
1,788,636 $154 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $965,311 - $1.09 Million
11,562 Added 0.62%
1,888,355 $172 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $2.49 Million - $2.79 Million
-33,915 Reduced 1.77%
1,876,793 $154 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $536,895 - $672,531
7,428 Added 0.39%
1,910,708 $146 Million
Q3 2021

Nov 10, 2021

SELL
$71.68 - $78.83 $385,280 - $423,711
-5,375 Reduced 0.28%
1,903,280 $143 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $803,643 - $888,911
-11,430 Reduced 0.6%
1,908,655 $148 Million
Q1 2021

Apr 28, 2021

SELL
$68.86 - $81.11 $2.78 Million - $3.27 Million
-40,336 Reduced 2.06%
1,920,085 $148 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $2.76 Million - $3.07 Million
-38,497 Reduced 1.93%
1,960,421 $160 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $1.32 Million - $1.49 Million
-17,981 Reduced 0.89%
1,998,918 $166 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $1.01 Million - $1.15 Million
-14,384 Reduced 0.71%
2,016,899 $156 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $449,856 - $623,522
-7,100 Reduced 0.35%
2,031,283 $156 Million
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $2.24 Million - $2.52 Million
-28,839 Reduced 1.4%
2,038,383 $185 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $781,645 - $852,022
-10,274 Reduced 0.49%
2,067,222 $174 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $998,991 - $1.17 Million
-14,304 Reduced 0.68%
2,077,496 $174 Million
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $1.48 Million - $1.69 Million
-21,336 Reduced 1.01%
2,091,800 $174 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $1.81 Million - $2.1 Million
-27,795 Reduced 1.3%
2,113,136 $161 Million
Q3 2018

Nov 01, 2018

SELL
$57.69 - $67.84 $1.62 Million - $1.9 Million
-28,034 Reduced 1.29%
2,140,931 $152 Million
Q2 2018

Aug 08, 2018

SELL
$50.83 - $59.72 $1.13 Million - $1.33 Million
-22,226 Reduced 1.01%
2,168,965 $132 Million
Q1 2018

May 08, 2018

SELL
$50.96 - $59.23 $597,709 - $694,708
-11,729 Reduced 0.53%
2,191,191 $119 Million
Q4 2017

Feb 02, 2018

SELL
$51.62 - $61.64 $3.09 Million - $3.69 Million
-59,810 Reduced 2.64%
2,202,920 $124 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $133 Million - $143 Million
2,262,730
2,262,730 $145 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.